Connect with us

Technology

Lakewood-Amedex Biotherapeutics Announces World-Renowned Expert David G. Armstrong, M.D., Ph.D., as Study Chair for Phase 2a Trial of Nu-3 in Infected Diabetic Foot Ulcers

Published

on

Leading clinician and surgeon to also serve as Scientific Advisor for Lakewood-Amedex Biotherapeutics’ iDFU program

SARASOTA, Fla., June 25, 2026 /PRNewswire/ — Lakewood-Amedex Biotherapeutics Inc., (NASDAQ: LABT, the “Company”), a clinical-stage biotechnology company advancing a novel class of potent, fast-acting, broad-spectrum antimicrobials for infectious diseases called the Bisphosphocin® class, today announced that David G. Armstrong, DPM, M.D., Ph.D., Distinguished Professor of Surgery and Neurological Surgery at the Keck School of Medicine of USC, has accepted the position of Study Chair for the Company’s Phase 2a clinical trial evaluating Nu-3 for the treatment of infected diabetic foot ulcers (iDFUs). Dr. Armstrong will also serve as a Scientific Advisor to Lakewood-Amedex Biotherapeutics on the iDFU program.

Dr. Armstrong is internationally recognized as one of the world’s foremost experts in diabetic foot care, including infection control, wound healing and limb preservation. Throughout his distinguished career, he has authored hundreds of peer-reviewed scientific publications and has helped shape modern approaches to preventing amputations and improving outcomes for patients with diabetes-related complications.

“We are honored to welcome Dr. Armstrong as Study Chair for our Phase 2a trial and as a Scientific Advisor to Lakewood-Amedex Biotherapeutics,” said Thomas Balzer, M.D., Ph.D., Chief Medical Officer of Lakewood-Amedex Biotherapeutics. “Dr. Armstrong’s unparalleled experience as both a surgeon and investigator in national and international clinical trials brings an important perspective to the study and our advancement of Bisphosphocin® antimicrobials. We look forward to working closely with him to evaluate the potential of Nu-3 and to further our understanding of how our novel topical antimicrobial therapies may help address persistent challenges in diabetic foot infection management.”

As Study Chair, Dr. Armstrong will provide scientific leadership and oversight for the Phase 2a study, helping guide the clinical evaluation of Nu-3, Lakewood-Amedex Biotherapeutics’ lead Bisphosphocin® antimicrobial candidate. The Phase 2a clinical trial is a proof-of-concept study designed to evaluate the safety and efficacy of topical Nu-3 gel in patients with infected diabetic foot ulcers. The study will evaluate three dose concentrations of Nu-3 (2%, 5% and 10%) and is intended to support advancement into a larger Phase 2b clinical study.

“Infected diabetic foot ulcers are a significant clinical challenge despite advances in wound care and limb preservation, and antibiotic resistance is a potentially grave concern in this patient population,” said Dr. Armstrong. “There remains a substantial need for new therapeutic approaches that can effectively address infection while supporting healing and minimizing the risk of developing resistance. A topical antimicrobial such as Nu-3 fits well with the ongoing evolution of diabetic foot ulcer management, and if clinical studies demonstrate its effectiveness, it has the potential to help address an important treatment gap for patients suffering from these serious infections. I look forward to working with Lakewood-Amedex Biotherapeutics to evaluate the potential of this novel therapeutic approach.”

About David G. Armstrong, DPM, M.D., Ph.D.
David G. Armstrong, DPM, M.D., Ph.D., is Distinguished Professor of Surgery and Neurological Surgery at the Keck School of Medicine of USC and a globally recognized leader in diabetic foot care, wound healing and limb preservation. His research and clinical work have focused on preventing amputations and improving outcomes for patients with diabetes-related complications. Dr. Armstrong has authored hundreds of peer-reviewed scientific publications and is widely regarded as one of the most influential voices in the field of diabetic foot disease and limb preservation.

About Lakewood-Amedex Biotherapeutics Inc.
Lakewood-Amedex Biotherapeutics Inc. (NASDAQ: LABT) is a clinical-stage biotechnology Company developing a novel class of fast-acting, broad-spectrum antimicrobials – the Bisphosphocin® class – to treat infectious diseases and reduce the threat posed by antibiotic-resistant bacterial strains, including MRSA, VRE, and others. For more information, please visit https://lakewoodamedex.com.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements regarding Lakewood-Amedex Biotherapeutics Inc.’s clinical development plans, regulatory strategy, anticipated trial timing, potential regulatory submissions or approvals, and the potential benefits, safety, efficacy and commercial potential of its Bisphosphocin® platform and product candidates. These statements are based on current expectations and assumptions and are subject to risks and uncertainties that could cause actual results to differ materially, including risks that clinical trials may not be initiated, completed or successful on expected timelines or at all; preclinical or clinical results may not be predictive of future results; product candidates may not demonstrate safety or efficacy or receive regulatory approval; and risks related to manufacturing, supply, financing and other matters described in the company’s SEC filings, including under “Risk Factors.” Forward-looking statements speak only as of the date of this press release, and the company undertakes no obligation to update them except as required by law.

Contact

Investor Relations
Tiberend Strategic Advisors, Inc.
David Irish
(231) 632-0002
dirish@tiberend.com

Media Relations
Tiberend Strategic Advisors, Inc.
Casey McDonald
646-577-8520
cmcdonald@tiberend.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/lakewood-amedex-biotherapeutics-announces-world-renowned-expert-david-g-armstrong-md-phd-as-study-chair-for-phase-2a-trial-of-nu-3-in-infected-diabetic-foot-ulcers-302809879.html

SOURCE Lakewood-Amedex Biotherapeutics Inc.

Continue Reading

Technology

Bringing Local AI Home: UGREEN Introduces Privacy-First HomeAgent for Smarter Living

Published

on

By

BERLIN, Sept. 5, 2026 /PRNewswire/ — UGREEN, a leading global consumer technology brand, announced two new product lineups at a European launch event. The unveiling of the UGREENHomeAgent series of agentic local AI hubs and a new MagFlow lineup marks UGREEN’s next stage of growth. Building on its established presence in digital accessories and smart storage, the company is now dedicated to a broader spectrum of intelligent consumer electronics designed to enhance everyday life.

UGREEN HomeAgent: Agentic Local AI Hub for Homes

At the center of UGREEN’s broader intelligent consumer electronics vision is UGREEN HomeAgent, a groundbreaking Agentic AI Local Hub unifying local storage, computing, and control into one device. It connects a growing ecosystem of UGREEN AIoT devices, including security cameras, smart speakers, and smart photo frames, as well as third-party devices.

UGOS Pro is UGREEN’s in-house operating system built on a Linux architecture, offering professional storage management, robust data security, easy backup and sync, and extensive expandability.

UGREEN HomeAgent is powered by the all-new UGOS Pro, combining NAS-grade storage and data management with integrated home security features, smart home capabilities, and natural voice interaction to deliver a more complete all-in-one experience.

Traditional surveillance cameras usually only document bad news, and their footage is constantly overwritten, so the moments truly worth keeping quietly disappear. That’s why UGREEN set out to redefine the home camera system, not as a surveillance tool, but as a camera for life.

“HomeAgent proactively recognizes moments that are truly worth remembering and organizes them into a personalized daily briefing for every family. Moments that might otherwise be forgotten can return. We want to help families preserve the precious time they spend together.” – Samuel Zhang, CEO of UGREEN

As an agentic local AI hub integrating on-device intelligence, local storage, AI computing and smart-home control, HomeAgent serves as the AI brain of the connected home. Designed to keep data private and local, it enables intelligent file management, proactive home monitoring, voice-driven automation and unified device control. The ecosystem includes the HomeAgent HA100 and HA100 Pro, the NVIDIA® Jetson Thor™-powered MasterAgent MA100, SynCare smart cameras, the UGREEN Smart Speaker for Uliya, and UGREEN Gallery smart frames, while remaining compatible with third-party Matter-enabled devices. Together, they deliver a private, expandable AI platform that helps users preserve memories, monitor their homes and coordinate devices through natural, context-aware interactions.

MagFlow Pro: Active Heat Dissipation and Sustained Fast Charging

Announced alongside HomeAgent, MagFlow Powerbank is the world’s first liquid-cooled Qi2 25W magnetic power bank, featuring CryoPulse™ micro-pump liquid cooling, active heat dissipation and sustained fast charging.

The launch complements UGREEN’s strong range of charging options, outlining the brand’s commitment to true-rated performance and flagship-quality power.

Availability Timeline

Pre-orders for the UGREEN HomeAgent HA100, HA100 Pro and UGREEN MasterAgent MA100 opened on September 4, 2026, via the UGREEN AIoT Official Store, and remain available until the official Kickstarter crowdfunding campaign launches on October 27, 2026. Other AIoT accessories will be introduced as part of the Kickstarter campaign beginning on October 27. During the pre-order period, customers can place a deposit starting at $50 to reserve the UGREEN HomeAgent HA100, HA100 Pro or UGREEN MasterAgent MA100 and secure 50% off with the Super Early Bird discount.

About UGREEN

UGREEN is a leading global tech brand creating innovative products that make everyday life smarter, easier, and more connected. From smart charging and productivity to smart storage and AIoT, UGREEN designs technology around the needs of modern life.

View original content to download multimedia:https://www.prnewswire.co.uk/news-releases/bringing-local-ai-home-ugreen-introduces-privacy-first-homeagent-for-smarter-living-302870674.html

Continue Reading

Technology

HKC and KOORUI Receive Dual Honors at the 2026 Global Product Technology Innovation Awards

Published

on

By

HKC receives the Advanced Display Technology Brand Award, while KOORUI is honored with the Innovative Monitor Brand Award during IFA 2026.

BERLIN, Sept. 5, 2026 /CNW/ — HKC and its consumer display brand KOORUI received two distinctions at the 2026 Global Product Technology Innovation Awards, presented in Berlin during IFA 2026.

HKC received the Advanced Display Technology Brand Award, recognizing its continued commitment to display technology and integrated display solutions. KOORUI received the Innovative Monitor Brand Award, highlighting the brand’s ongoing efforts in monitor innovation and user experience.

According to the organizer, the Global Product Technology Innovation Awards were established by IDG in 2014 to recognize outstanding brands and products across the global consumer electronics and home appliance industries. Presented annually in Berlin during IFA, the awards highlight notable achievements in technology and product innovation for audiences across Europe and global markets.

As display technologies and applications continue to evolve, users increasingly expect products that combine strong performance, high quality and meaningful visual experiences. With more than 20 years of focus on display technology, HKC has developed into a global provider of integrated display solutions. KOORUI builds on this technological foundation to bring innovative monitor products to a broader range of consumers and usage scenarios.

“We are honored to receive these two awards,” said a representative of HKC Group. “They recognize HKC’s long-term commitment to display technology and KOORUI’s continued focus on product innovation. We will keep developing advanced display solutions that respond to evolving user needs and create high-quality visual experiences worldwide.”

The two honors mark another milestone for HKC and KOORUI as they continue advancing display technologies, improving product experiences and strengthening engagement with global partners and consumers.

About HKC

HKC has focused on the display industry for more than 20 years and provides integrated display solutions for global markets and diverse applications.

About KOORUI

KOORUI is HKC’s consumer display brand, creating innovative monitor products and visual experiences for users worldwide.

View original content:https://www.prnewswire.com/news-releases/hkc-and-koorui-receive-dual-honors-at-the-2026-global-product-technology-innovation-awards-302870688.html

SOURCE HKC

Continue Reading

Technology

ATTACK SHARK Announces Strategic Partnership with Cloud9 Esports’ League of Legends Team

Published

on

By

NEW YORK, Sept. 5, 2026 /PRNewswire/ — High-performance gaming peripheral brand ATTACK SHARK today announced a partnership with leading esports organization Cloud9 Esports. Focused on Cloud9’s League of Legends team, the collaboration will showcase professional gaming insights, esports culture, and competitive gear content across digital, social media, and e-commerce channels.

A Championship Legacy in North American Esports

Founded in 2013, Cloud9 Kia has grown into one of North America’s most iconic esports organizations. Originally established through League of Legends, it has built a global reputation through competitive success, including 6 League Championship Series (LCS) titles, 10 World Championship appearances, the 2018 ELEAGUE Major Boston title, the inaugural Overwatch League championship, and a Rocket League World Championship. Cloud9 Kia remains one of North America’s most influential League of Legends teams.

Deep Collaboration: From Pro Scenes to Player Communities

The partnership will center on professional player training, competitive performance, and player-focused content. ATTACK SHARK will equip the Cloud9 League of Legends team with its latest gaming peripherals to support daily training and competitive preparation.

By combining Cloud9’s professional competitive expertise with ATTACK SHARK’s focus on hardware innovation, the partnership aims to explore the increasing demands placed on gaming equipment in high-level esports environments. Trusted by over 10 million players worldwide, ATTACK SHARK translates professional esports insights into accessible, high-performance gaming peripherals for competitive gamers. 

“At Cloud9 Kia, we believe gaming can unlock the best in everyone. ATTACK SHARK is on a mission to make high-performance mice and keyboards accessible to all gamers, and that’s the same idea from two directions. I’m proud to have them alongside Cloud9 Kia, and excited for all of the amazing peripherals this partnership will put into our fan’s hands,” said Jonathan Tran, President of Cloud9.

“Partnering with Cloud9 Kia is a significant milestone for ATTACK SHARK,” said Gavin Cheng, CEO and Co-Founder of ATTACK SHARK. “Their competitive spirit, professionalism, and relentless pursuit of excellence closely align with the values that have guided ATTACK SHARK from the beginning. This collaboration creates an opportunity to learn from professional competition and share those insights with players around the world.”

The partnership represents a deeper investment by ATTACK SHARK in the global esports ecosystem. Together, ATTACK SHARK and Cloud9 Kia will continue creating new experiences for competitive players and gaming communities worldwide.

For more information, visit https://attackshark.com/ or connect with the brand on social media and Discord.

View original content to download multimedia:https://www.prnewswire.com/news-releases/attack-shark-announces-strategic-partnership-with-cloud9-esports-league-of-legends-team-302870659.html

SOURCE ATTACK SHARK

Continue Reading

Trending